Barfresh Food (BRFH) 10-K 14 Apr 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 15, 2021	Jun. 30, 2020
Cover [Abstract]
Entity Registrant Name	BARFRESH FOOD GROUP INC.
Entity Central Index Key	0001487197
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Reporting Status Current	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 25,051,007
Entity Common Stock, Shares Outstanding		149,133,372
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 1,816,887	$ 999,989
Restricted cash	142,382	91,385
Accounts receivable, net	425,029	284,668
Inventory, net	870,190	634,746
Prepaid expenses and other current assets	47,066	17,606
Total current assets	3,301,554	2,028,394
Property, plant and equipment, net of depreciation	1,922,912	2,406,317
Operating lease right-of-use assets, net	147,947	203,287
Intangible assets, net of amortization	430,216	479,503
Deposits	14,817	8,304
Total Assets	5,817,446	5,125,805
Current liabilities:
Accounts payable	353,046	625,068
Accrued expenses	298,489	250,125
Advance payment	401,306
Accrued payroll	191,137	215,601
Accrued vacation	117,166	95,851
Accrued interest	68,627	487,978
Lease liability	65,007	56,692
Loan payable - Paycheck Protection Program	410,317
Convertible note, net of discount	158,243	150,742
Derivative liabilities	41,475
Total current liabilities	2,104,813	1,882,057
Long term liabilities:
Accrued interest	127,664
Lease liability	94,170	159,177
Loan payable - Paycheck Protection Program	157,814
Convertible note - related party, net of discount	197,804	1,181,942
Convertible note, net of discount	810,995	1,407,877
Derivative liabilities		211,028
Total liabilities	3,493,260	4,842,081
Commitments and contingencies (Note 6,7,8 and 13)
Stockholders' equity:
Preferred stock, $0.000001 par value, 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.000001 par value; 295,000,000 shares authorized; 149,133,372 and 130,341,737 shares issued and outstanding at December 30, 2020and 2019, respectively	149	130
Additional paid in capital	53,223,665	47,030,716
Accumulated deficit	(50,899,628)	(46,747,122)
Total stockholders' equity	2,324,186	283,724
Total Liabilities and Stockholders' Equity	$ 5,817,446	$ 5,125,805

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.000001	$ 0.000001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.000001	$ 0.000001
Common stock, shares authorized	295,000,000	295,000,000
Common stock, shares issued	149,133,372	130,341,737
Common stock, shares outstanding	149,133,372	130,341,737

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 2,567,547	$ 4,306,785
Cost of revenue	1,784,537	1,928,210
Depreciation of manufacturing equipment	18,938	65,366
Gross profit	764,072	2,313,209
Operating expenses:
General and administrative	4,379,976	6,850,566
Depreciation and amortization	593,198	649,847
Total operating expenses	4,973,174	7,500,413
Operating loss	(4,209,102)	(5,187,204)
Other (income)/expenses
(Gain) from derivative liability	(156,540)	(1,114,625)
(Gain) from debt extinguishment	(379,200)
Warrant modification		307,460
Interest expense	479,144	1,213,263
Total other (income) expense	(56,596)	406,098
Net (loss)	$ (4,152,506)	$ (5,593,302)
Per share information - basic and fully diluted:
Weighted average shares outstanding	138,755,506	128,510,646
Net (loss) per share	$ (0.03)	$ (0.04)

Statement of Stockholders' Equi

Statement of Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid in Capital [Member]	Accumulated (Deficit) [Member]	Total
Beginning balance at Dec. 31, 2018	$ 123	$ 41,118,649	$ (41,153,820)	$ (35,048)
Beginning balance, shares at Dec. 31, 2018	122,770,960
Exercise of warrants	$ 3	1,884,873		1,884,876
Exercise of warrants, shares	3,196,180
Issuance of stock and options for services		335,914		335,914
Issuance of stock and options for services, shares	374,597
Equity based compensation		225,026		225,026
Warrants issued to Management		758,798		758,798
Issuance of stock for capital raise, net of offering costs	$ 4	2,399,996		2,400,000
Issuance of stock for capital raise, net of offering costs, shares	4,000,000
Warrant modification		307,460		307,460
Net (loss) for the year			(5,593,302)	(5,593,302)
Ending balance at Dec. 31, 2019	$ 130	47,030,716	(46,747,122)	283,724
Ending balance, shares at Dec. 31, 2019	130,341,737
Equity based compensation		276,641		276,641
Warrants issued to Management		167,893		167,893
Issuance of stock for capital raise, net of offering costs	$ 13	3,797,787		3,797,800
Issuance of stock for capital raise, net of offering costs, shares	12,972,868
Warrant modification		18,899		18,899
Conversion of debt	$ 5	1,333,757		$ 1,333,762
Conversion of debt, shares	4,770,030			4,770,030
Interest paid in shares	$ 1	392,788		$ 392,789
Interest paid in shares, shares	654,651
Issuance of stock for services		130,000		130,000
Issuance of stock for services, shares	272,559
Warrant issued for note extension		75,184		75,184
Restricted stock issuance
Restricted stock issuance, shares	121,527
Net (loss) for the year			(4,152,506)	(4,152,506)
Ending balance at Dec. 31, 2020	$ 149	$ 53,223,665	$ (50,899,628)	$ 2,324,186
Ending balance, shares at Dec. 31, 2020	149,133,372

Statement of Stockholders' Eq_2

Statement of Stockholders' Equity (Parenthetical)	12 Months Ended
	Dec. 31, 2020USD ($)
Statement of Stockholders' Equity [Abstract]
Offering costs	$ 27,200

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement of Cash Flows [Abstract]
Net loss	$ (4,152,506)	$ (5,593,302)
Adjustments to reconcile net loss to net cash used for operating activities
Depreciation	548,323	651,603
Amortization	63,813	63,610
Amortization of right of use asset	55,340	38,268
Change in allowance for doubtful accounts	(8,364)	89,397
Change in inventory reserve	(41,558)	69,414
Interest expense related to debt discount	276,013	881,871
Warrant modification expense		307,460
Stock-based compensation	276,641	225,026
Stock and options issued for services	130,000	335,914
Gain on derivative	(156,540)	(1,114,625)
Gain on debt extinguishment	(379,200)
Changes in assets and liabilities
Accounts receivable	(131,997)	(16,757)
Inventories	(199,142)	456,938
Prepaid expenses and other assets	(29,460)	41,482
Deposits	(6,513)	31,065
Accounts payable	(272,022)	(502,376)
Accrued expenses	213,107	350,780
Advanced payments	401,306
Accrued interest	214,917	331,432
Net Cash (used for) operating activities	(3,197,782)	(3,353,326)
Investing Activities
Purchase of property and equipment	(59,662)	(466,216)
Purchase of intangibles	(14,526)	(5,324)
Net Cash (used for) investing activities	(74,188)	(471,540)
Financing Activities
Cash received for warrant exercises		1,500,357
Cash received for stock, net of offering costs	3,797,800	2,400,000
Repayments of convertible notes	(157,366)
Proceeds from note payable	568,131
Debt issuance costs	(12,008)
Payments of operating leases	(56,692)	(25,686)
Net Cash from financing activities	4,139,865	3,874,671
Net change in cash and restricted cash	867,895	49,805
Cash and restricted cash, beginning of year	1,091,374	1,041,569
Cash and restricted cash, end of year	1,959,269	1,091,374
Cash payments for interest	2,775
Non-cash financing and investing activities
Total property and equipment included in accounts payable		26,084
Debt discount warrant and derivative liability	107,611
Convertible notes principal and interest settled through warrant exercise		384,563
Operating lease right-of-use asset		241,555
Deferred compensation settled through issuance of warrants	167,893	758,798
Net carrying value of convertible notes and accrued interest settled through issuance of stock (debt extinguishment)	1,770,963
Accrued interest settled through issuance of stock	$ 392,789

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1. Summary of Significant Accounting Policies Barfresh Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February 25, 2010 in the State of Delaware. We are engaged in the manufacturing and distribution of ready to blend beverages, particularly, smoothies, shakes and frappes. The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Basis of Consolidation The consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been eliminated upon consolidation. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. Concentration of Credit Risk The amount of cash on deposit with financial institutions exceeds the $250,000 federally insured limit at December 31, 2020 and 2019. However, we believe that cash on deposit that exceeds $250,000 in the financial institutions is financially sound and the risk of loss is minimal. Restricted Cash At December 31, 2020, the Company had $142,382 and $91,385, respectively, in restricted cash related to our co-packing agreement. Fair Value Measurement Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 - Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs. Level 3 - Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights. Our financial instruments consist of cash, accounts receivable, accounts payable, advanced payments, derivative liabilities, convertible notes, restricted cash, and PPP loan payable. The carrying value of our financial instruments approximates their fair value, except for the derivative liability in which carrying value is fair value. Accounts Receivable Accounts receivable are typically unsecured. Our credit policy calls for payment generally within 30 days. The credit worthiness of a customer is evaluated prior to a sale. As of December 31, 2020, and 2019, the company’s allowance for doubtful accounts was $133,424 and $141,788 respectively. There was $133,424 of bad debt expense recorded for the year ended December 31, 2020 and $89,397 of bad debt expense for the year ended December 31, 2019. The allowance was applied to certain receivable accounts which are over 95 days. Inventory Inventory consists of finished goods and is carried at the lower of cost or net realizable value on a first in first out basis. The company monitors the remaining useful life of its inventory and establishes a reserve of obsolescence where appropriate. As of December 31, 2020 and 2019, the Company’s inventory reserve was $59,093 and $100,651 respectively. Intangible Assets Intangible assets are comprised of patents, net of amortization and trademarks. The patent costs are being amortized over the life of the patent, which is twenty years from the date of filing the patent application. In accordance with ASC Topic 350 Intangibles - Goodwill and Other In accordance with ASC 350 legal costs related to trademarks have been capitalized. We have determined that trademarks have an indeterminable life and therefore are not being amortized. Long-Lived Assets and Other Acquired Intangible Assets We evaluate the recoverability of property and equipment and finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of property and equipment and intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. We have not recorded any impairment charges during the years presented. Property, Plant, and Equipment Property, plant, and equipment is stated at cost less accumulated depreciation and accumulated impairment loss, if any. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. Leasehold improvements are being amortized over the shorter of the useful life of the asset or the lease term that includes any expected renewal periods that are deemed to be reasonably assured. The estimated useful lives used for financial statement purposes are: Furniture and fixtures: 5 years Manufacturing equipment and customer equipment: 3 years to 7 years Vehicles: 5 years Revenue Recognition In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps: 1) Identify the contract with a customer A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers. 2) Identify the performance obligation in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer. 3) Determine the transaction price The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically includes volume-based rebates or discounts, are estimated utilizing the most likely amount method. 4) Allocate the transaction price to performance obligations in the contract Since our contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation. 5) Recognize Revenue when or as the Company satisfies a performance obligation The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and handling costs are treated as fulfillment costs and presented in distribution, selling and administrative costs. Payments that are received before performance obligations are recorded are shown as current liabilities. The company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single product, frozen beverages. Research and Development Expenditures for research activities relating to product development and improvement are charged to expense as incurred. We incurred $515,145 and $538,391, in research and development expenses for the years ended December 31, 2020 and 2019, respectively. Shipping and Storage Costs Shipping and handling costs are included in general and administrative expenses. For the years ended December 31, 2020 and 2019, shipping and handling costs totaled $488,465 and $751,237, respectively. Leases We determine if an arrangement is a lease upon inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The right to control the use of an asset includes the right to obtain substantially all of the economic benefits of the underlying asset and the right to direct how and for what purpose the asset is used. After adoption of ASU 2016-02 and related standards, operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Lease expense is recognized on a straight-line basis over the lease term. As a lessee, the Company leases office space. Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements, uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all of the deferred tax assets will not be recognized. For the years ended December 31, 2020 and 2019 we did not have any interest and penalties or any significant unrecognized uncertain tax positions. Derivative Liability The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging.” The result of this accounting treatment is that the fair value of any derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as gain/loss from derivative liability. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. We analyzed the derivative financial instruments in accordance with ASC 815. The objective is to provide guidance for determining whether an equity-linked financial instrument is indexed to an entity’s own stock. This determination is needed for a scope exception which would enable a derivative instrument to be accounted for under the accrual method. The classification of a non-derivative instrument that falls within the scope of ASC 815-40-05 “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” also hinges on whether the instrument is indexed to an entity’s own stock. A non-derivative instrument that is not indexed to an entity’s own stock cannot be classified as equity and must be accounted for as a liability. There is a two-step approach in determining whether an instrument or embedded feature is indexed to an entity’s own stock. First, the instrument’s contingent exercise provisions, if any, must be evaluated, followed by an evaluation of the instrument’s settlement provisions. The Company utilized the fair value standard set forth by the Financial Accounting Standards Board, defined as the amount at which the assets (or liability) could be bought (or incurred) or sold (or settled) in a current transaction between willing parties, that is, other than in a forced or liquidation sale. Earnings per Share We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share Stock Based Compensation We calculate stock compensation in accordance with ASC Topic 718, Compensation-Stock Based Compensation Recent pronouncements From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory	Note 2. Invento Inventory consists of the following at December 31: 2020 2019 Raw materials $ 130,296 $ 286,028 Finished goods 798,987 449,369 Inventory reserve (59,093 ) (100,651 ) Inventory, net $ 870,190 $ 634,746

Property Plant and Equipment

Property Plant and Equipment	12 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Property Plant and Equipment	Note 3. Property Plant and Equipment Major classes of property and equipment at December 31, 2020 and 2019 consist of the following: 2020 2019 Furniture and fixtures $ 1,524 $ 1,524 Manufacturing Equipment and customer equipment 3,573,528 3,521,636 Leasehold Improvements 4,886 4,886 Vehicles 29,696 29,696 3,609,634 3,557,742 Less: accumulated depreciation (2,331,034 ) (1,787,967 ) 1,278,600 1,769,775 Equipment not yet placed in service 644,312 636,542 Property and equipment, net of depreciation $ 1,922,912 $ 2,406,317 We recorded depreciation expense related to these assets of $529,385 and $586,237 for the years ended December 31, 2020 and 2019, respectively. Depreciation expense in Cost of Goods Sold was $18,938 and $65,366 for the years ended December 31, 2020 and 2019 respectively.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 4. Intangible Assets As of December 31, 2020, intangible assets consist of patent costs of $768,138, trademarks of $119,911 and accumulated amortization of $457,833. As of December 31, 2019, intangible assets consist of patent costs of $764,891, trademarks of $108,632 and accumulated amortization of $394,020. The amounts carried on the balance sheet represent cost to acquire, legal fees and similar costs relating to the patents incurred by the Company. Amortization is calculated through the expiration date of the patent, which is December 2025. The amount charged to expenses for amortization of the patent costs was $63,813 and $63,610 for the years ended December 31, 2020 and 2019, respectively. Estimated future amortization expense related to patents as of December 31, 2020, is as follows: Years ending December 31, Total Amortization 2021 $ 64,422 2022 64,422 2023 64,422 2024 64,218 2025 52,821 $ 310,305

Related Parties

Related Parties	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Parties	Note 5. Related Parties As disclosed below in Note 7, members of management and directors invested in company’s convertible notes; and in Note 10, members of management and directors have received shares of stock and options in exchange for services.

Paycheck Protection Program (PP

Paycheck Protection Program (PPP) Loan	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Paycheck Protection Program (PPP) Loan	Note 6. Paycheck Protection Program (PPP) loan The Company was granted a $568,131 loan under the PPP administered by a Small Business Administration (SBA) approved partner. The loan, which matures in two years, is uncollateralized and is fully guaranteed by the Federal government. The Company is eligible for loan forgiveness of up to 100% of the loan, upon meeting certain requirements. The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. No forgiveness income has been recorded for the year ended December 31, 2020. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven. The company has applied for and anticipates the loan to be forgiven in 2021.

Convertible Notes (Related and

Convertible Notes (Related and Unrelated Party)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Convertible Notes (Related and Unrelated Party)	Note 7. Convertible Notes (Related and Unrelated Party) In March 2018, we closed an offering of $2,527,500 in convertible notes, Series CN Note 1 of 2, of which, management, directors and significant shareholders have invested $840,000. The convertible notes bear 10% interest per annum and are due and payable on March 14, 2020. The notes are convertible at any time prior to the due date into our common stock at conversion price of $0.88 per share or 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders’ election; but in no event lower than $0.60 per share. In addition, the interest is convertible at any time prior to the due dates into our common stock at conversion price of 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders’ election; but in no event lower than $0.60 per share. There were 1,331,583 warrants issued, in conjunction with the convertible note offering. The fair value of the warrants, $0.17 per share ($220,548 in the aggregate), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 3 Volatility (based on a comparable company) 54.82 % Risk Free interest rate 2.41 % Dividend yield (on common stock) - The value of $220,548 was recorded as a debt discount related to the issuance of the warrants. In April 2018, we offered investors in our March 2018 Convertible Note (“Series CN Notes”) the opportunity to accelerate the issuance of certain warrants associated with the CN Notes. Pursuant to the acceleration offer, Series CN Notes investors who invested an additional 10% to 20% of the Series CN Note amount, immediately received an additional 25% warrant coverage on their initial CN Note investment, which would otherwise have been issued after one year. During April 2018, we closed the CN Note acceleration offer in the amount of $177,300 in convertible notes, of which, management, directors and significant shareholders have invested $30,000. The CN Note acceleration offer convertible notes bear 10% interest per annum and are due and payable on March 14, 2020. The notes are convertible at any time prior to the due date into our common stock at conversion price of $0.88 per share or 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders’ election; but in no event lower than $0.60 per share. In addition, the interest is convertible at any time prior to the due dates into our common stock at conversion price of 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders’ election; but in no event lower than $0.60 per share. There were 937,373 warrants issued in conjunction with the Series CN Note acceleration offer convertible note offering. The fair value of the warrants, $0.25 per share ($235,519 in the aggregate), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 3 Volatility (based on a comparable company) 55.49 % Risk Free interest rate 2.45 % Dividend yield (on common stock) - The value of $105,199 was recorded as a debt discount related to the issuance of the warrants as using the fair value would cause the debt discount to exceed the gross proceeds received. In March 2019, an investor elected to exercise I-Warrants by using part of the investor’s convertible note. The total debt settled was $350,634 of principal and $33,929 of accrued interest. On March 20, 2020, we completed a Private Placement offering of $3,825,000 of common stock. In connection with the transaction, the Company offered the Convertible Noteholders of Series CN Note 1 and 2 to participate in the equity offering. A total of $720,000 principal balance of Series CN 1 was converted into common stock [$630,000 from related parties]. The Series CN Note 1 Noteholders were offered bonus interest equivalent to 20% of their outstanding principal which was converted to common stock. For $1,071,000 of the remaining $1,186,167 Series CN Note 1 Noteholders that chose not to participate in the equity offering, the terms of the Series CN Note 1 were amended to increase the interest rate to 15% per annum and to extend the maturity of the outstanding principal balance by 24 months to March 20, 2022. The notes are convertible at any time prior to the maturity into our common stock at a conversion price of $0.50 per share. If the six month price is less than the $0.50 per share, the principal conversion price will be automatically reduced to the $0.50 per share, but in no event less than $0.35 per Share, in which case the Company shall issue to each purchaser, based on such purchaser’s investment, (a) shares in a quantity that equals the difference between the number of Shares issued to such purchaser at closing and the number of Shares that would have been issued to such purchaser at closing at the $0.50 per share and (b) warrants in a quantity that equals fifty percent (50%) of the difference between the number of shares issued to such Purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the $0.50 per share, with an exercise price that equals the sum of $0.10 per share and the $0.50 per share, but in no event less than $0.45 per share. The exercise price per share for the Convertible Note Warrants and the Bonus Warrant issued at closing will automatically adjust as well to the sum of $0.10 per share and the Six Month Price, but in no event less than $0.45 per share. There were 864,000 O warrants issued to the Series CN Note 1 Noteholders for participating in the common stock offering. On March 20, 2020, 1,082,727 of the original L Warrants related to the Series CN Note 1 Noteholders had their terms modified, whereby the exercise price was reduced from $0.70 to $0.50 per share. In addition, the Series CN Note 1 Noteholders that chose to extend their notes for 24 months were granted 1,071,000 Series P warrants. The fair value of the warrants, ($92,266 in the aggregate which consists of the L and P Warrants), were calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1 to 3 Volatility 76.74- 98.00 % Risk Free interest rate .15 - .41 % Dividend yield (on common stock) - Based on the relative fair value, we recorded a debt discount of $75,184 related to the issue of P Warrants to CN 1 and CN 2 Noteholders. The modification of the L Warrants resulted in an incremental increase in fair value of $17,082, which was recorded as a debt discount. The convertible notes consist of the following components as of December 31, 2020 and December 31, 2019: 2020 2019 Convertible notes $ 1,181,167 $ 2,704,800 Less: Debt discount (warrant value) (92,266 ) (325,747 ) Less: Debt discount (derivative value) (Note 8) - (638,988 ) Less: Debt discount (issuance costs paid) (6,004 ) (27,000 ) Less: Note repayments/conversion (110,166 ) (803,634 ) Add: Debt discount amortization 38,173 898,940 $ 1,010,904 $ 1,808,371 In December 2018, we closed an offering of $1,363,200 in convertible notes, Series CN 2 of 2, of which, management, directors and significant shareholders have invested $560,000. The convertible notes bear 10% interest per annum and are due and payable on November 30, 2020. The notes are convertible at any time prior to the due date into our common stock at conversion price of $0.88 per share or 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders’ election; but in no event lower than $0.60 per share. In addition, the interest is convertible at any time prior to the due dates into our common stock at conversion price of 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders’ election; but in no event lower than $0.60 per share. There were 678,864 warrants issued, in conjunction with the convertible note offering. The fair value of the warrants, $0.31 per share ($212,763 in the aggregate), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 3 Volatility (based on a comparable company) 59.00 % Risk Free interest rate 2.83 % Dividend yield (on common stock) - The value of $212,763 was recorded as a debt discount related to the issuance of the warrants. On March 20, 2020, a total of $1,128,000 principal balance of Series CN Note 2 was converted into common stock [$560,000 from related parties]. The Noteholders were offered bonus interest equivalent to 20% of their outstanding principal and converted their accrued interest into common stock. For $168,000 of the remaining $235,200 Series CN Note 2 Noteholders that chose not to participate in the equity offering, the terms of the Series CN Note 2 were amended to extend the maturity of the outstanding principal balance by 12 months to November 30, 2021. The notes are convertible at any time prior to the maturity into our common stock at a conversion price of $0.60 per share. There were 1,501,012 O warrants issued to the Series CN Note 2 Noteholders for participating in the common stock offering. The fair value of the modified L warrants, ($4,279 prior to modification, and $6,096 post modification), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1.71 Volatility 88.02 % Risk Free interest rate 0.37 % Dividend yield (on common stock) - The incremental value of $1,817 was recorded as a debt discount related to the modification of existing L warrants. The convertible notes consist of the following components as of December 31, 2020 and December 31, 2019: 2020 2019 Convertible notes $ 235,200 $ 1,363,200 Less: Debt discount (warrant value) (1,817 ) (212,763 ) Less: Debt discount (derivative value) (Note 8) (13,528 ) (697,186 ) Less: Debt discount (issuance costs paid) (6,004 ) (23,700 ) Less: Note repayments (67,200 ) - Add: Debt discount amortization 9,487 502,639 $ 156,138 $ 938,190 The total of the two tables above at December 31, 2020, net of discount, equals $1,167,042 which is presented on the consolidated balance sheet as, $158,243 Convertible Note, net of discount, Current Liabilities, $197,804 Convertible Note, Related Party, Net of Discount, Long-Term Liabilities and $810,995 Convertible Note, Net of Discount, Long-term Liabilities. The total of $2,740,561 shown in the two tables above at December 31, 2019, are presented in the balance sheet as Long-Term Liabilities: Convertible Note – related party net of discount, of $1,181,942, Convertible Note – net of Discount of $1,407,877, and Current Liabilities: Convertible Note – net of Discount $150,742. Future maturity of convertible notes at face value before effect of all discount, are as follow: Years Ending December 31, Total Convertible Notes 2021 $ 168,000 2022 1,071,000 $ 1,139,000 On March 20, 2020, the Company and the Holders of the Series CN Note 1 and Note 2 mutually agreed to amend its terms to change the maturity date to March 20, 2022 and November 30, 2021, respectively. The Company accounted for the modification in accordance with ASC 470-50, Modifications and Extinguishments, which states that for all extinguishments of debt, the difference between the reacquisition price (including any premium) and the net carrying amount of the debt being extinguished (including any deferred debt issuance costs) should be recognized as a gain or loss when the debt is extinguished. Accordingly, the Company recorded a net gain on extinguishment of debt of $379,200 which was comprised of a gain of $437,201, offset by a loss of $58,001. The gain of $437,201 related to the portion of Convertible Notes that were converted to common stock on March 20, 2020. The loss on extinguishment of debt of $58,001 related to the portion of Convertible Notes that were extended by either 24 months for CN I, or 12 months for CN2.

Derivative Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	Note 8. Derivative Liabilities As discussed in Note 7, Convertible Notes, the Company issued Series CN Note acceleration offer convertible notes payable that provide variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock to be issued is based on the future price of the Company’s common stock, therefore the number of shares of common stock issuable upon conversion of the promissory note is indeterminate. The fair values of the Company’s derivative liabilities are estimated at the issuance date and are revalued at each subsequent report date. The derivative liability was revalued at December 31, 2019 with a value of $211,028, which resulted in a gain of $1,114,625 for the year then ended. As discussed in Note 7, there was a portion of the CN1 and CN2 notes that was not modified. The Company continued to revalue the derivative liability for each reporting period in 2020. At December 31, 2020, there was no value as the Company settled the derivative liability through repayment of the outstanding principal upon maturity. On March 20, 2020, the Company determined the fair value of the derivative liability related to CN1 and CN2 notes that were converted and extended. The derivative liability values of $23,100 (CN converted) and $3,440 (CN extended) were used to determine the debt extinguishment gain or loss. The fair value of the derivative liability for CN notes that were converted and CN notes that were extended was calculated using the Black-Scholes model using the following assumptions: March 20, 2020 Expected life (in years) 0.71 Volatility 84.82 % Risk Free interest rate 0.5 % Dividend yield (on common stock) - As the variable conversion provisions were not modified for $168,000 of CN2 notes that were extended to November 2021, the Company valued the derivative liability as of March 20, 2020. As of March 20, 2020, the initial value of the derivative liability was $13,527. The fair value of the derivative liability for CN2 notes that were extended was calculated using the Black-Scholes model using the following assumptions: March 20, 2020 Expected life (in years) 1.71 Volatility 88.02 % Risk Free interest rate 0.37 % Dividend yield (on common stock) - The fair value of the derivative liabilities for CN Convertible Note 2 of 2 was calculated using the Black-Scholes model using the following assumptions. December 31, 2020 December 31, 2019 Expected life 0.92 0.93 Volatility 120.38 % 104.89 % Risk Free interest rate .1 % 1.58 % Dividend yield (on common stock) - - Reconciliation of the derivative liability measured at fair value on a recurring basis with the use of significant unobservable inputs (level 3) from December 31, 2018 to December 31, 2019: December 31, 2018 $ 1,325,653 Loss from change in value (1,114,625 ) For the period ended December 31, 2019 $ 211,028 Reconciliation of the derivative liabilities measured at fair value on a recurring basis with the use of significant unobservable inputs (level 3) from December 31, 2019 to December 31, 2020: December 31, 2019 $ 211,028 Extinguishment change in derivative from conversion (23,100 ) Extinguishment change in derivative from extension (3,440 ) Initial derivative value – March 20, 2020 13,527 Net gain from change in value (156,540 ) For the period ended December 31, 2020 $ 41,475 The following table presents the Company’s fair value hierarchy for applicable assets and liabilities measured at fair value as of December 31, 2019 and December 31, 2020: Level 1 Level 2 Level 3 Total Derivative Liability December 31, 2019 $ - - 211,028 $ 211,028 Level 1 Level 2 Level 3 Total Derivative Liability December 31, 2020 $ - - 41,475 $ 41,475

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9. Commitments and Contingencies We lease office space under non-cancelable operating lease which expires on March 31, 2023. We incurred lease expense of $82,194 and $92,608 for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, our right of use asset and related liability was $147,947 and $159,177, respectively. In determining the present value of our operating lease right-of-use asset and liability, we used a 10% discount rate (which approximates our borrowing rate). The remaining term on the lease is 2.25 years. The following table presents the future operating lease payment as of December 31, 2020. 2021 $ 78,021 2022 80,361 2023 20,238 Total Lease payments 178,620 Less: imputed interest (19,443 ) Total lease liability $ 159,177 From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently the defendant in one legal proceeding for an amount less than $100,000. Our legal counsel and management believe a material unfavorable outcome to be remote.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	Note 10. Stockholders’ Equity During the year ended December 31, 2019, we issued 282,944 shares of common stock, valued at $169,040 for services. We also issued 91,653 shares of our common stock, with a value of $50,000, to a member of our Board of Directors in lieu of cash payments for Director fees. In addition, we issued 281,343 options to purchase our common stock to certain member of the Board of Directors in lieu of cash payments for Director fees valued at $116,874. The exercise price of the options ranged from $0.47 to $0.65 per share, vest immediately, and are exercisable for periods of 8 years. In addition, we issued 875,000 options to purchase our common stock to employees and executives. The exercise price of the options ranged from $0.45 to $0.73 per share, vest after 3 years, and are exercisable for periods of 8 years. The fair value of the options issued ($237,850, in the aggregate) was calculated using the Black-Sholes option pricing model, based on the criteria shown below. Expected life (in years) 5.5 to 8 Volatility (based on a comparable company) 59.82% to 77.19 % Risk Free interest rate 1.79% to 2.78 % Dividend yield (on common stock) - During the same period, we cancelled 1,387,333 options to purchase our common stock, which was primarily driven by the resignation of executives. The Holders of 2,841,454 warrants elected to exercise those warrant on a cash basis of $1,320,313 and cashless basis of $384,563 to offset convertible note and accrued interest; and received 2,841,454 shares of our common stock. The Holder of 300,000 warrants elected to exercise those warrant on a cash basis of $180,000 and received 300,000 shares of our common stock. During the year ended December 31, 2019, the Company completed additional funding including a Private Placement Offering for common shares priced at $0.60 per share, resulting in the receipt of proceeds in the amount of $2.4 million and the issuance of 4,000,000 shares. In addition, the Company settled certain Executive Deferred Compensation payments with a combination of cash and warrants. The total amount of Deferred Executive compensation settled is $771,113. One-third of that total or $243,623, was paid in cash. The remaining balance of $487,246 was settled by granting the Executives warrants exercisable for five years to purchase the Company’s stock at an exercise price of $0.70 per share. During the year ended December 31, 2020, the Company completed a funding, including a Private Placement Offering for common shares priced at $0.50 per share (subject to adjustment) in the amount of $3,825,000 and the issuance of 7,650,000 shares. The investors of this Private Placement Offering were granted O warrants to be eligible to purchase an additional 0.50 shares for every share issued to each purchaser, exercisable for a period of 3 years at an exercise price of $0.60 per share (subject to adjustment). If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the “Six Month Price”) exceeds or equals $0.50 per share (the “Target Price”), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor’s investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share. On September 28, 2020, the Company determined the volume-weighted average price was below the $0.35 per share and consequently issued 5,322,868 additional shares in accordance with provisions of the Private Placement Offering. Similarly, the Company issued an additional 2,652,868 Warrants to investors that contributed capital or exercised the conversion of their convertible note. Lastly, the Company issued an additional 459,000 Warrants for convertible noteholders that extended their convertible notes. In addition, at the Company’s option, we issued 654,651 shares of our Common Stock to pay interest due of $392,789. We issued 272,559 shares of our Common Stock for services rendered. The shares of our common stock were valued between $0.25 - $0.50 per share During the year ended December 31, 2020, we issued 870,000 options to purchase our common stock to employees and 199,358 options to a Board Member. The exercise price of the options was between $0.34 and $0.44 per share, with both cliff and graded vesting over 3 years, and are exercisable for a period of 8 years. The fair value of the options issued ($217,650, in the aggregate) was calculated using the Black-Sholes option pricing model, based on the criteria shown below. Expected life (in years) 5.5 to 8 Volatility (based on a comparable company) 73.36%-75.82 % Risk Free interest rate 0.30%-1.61 % Dividend yield (on common stock) - For the year ended December 31, 2020, 625,423 options expired or were cancelled. During the first quarter of 2020, the Company settled certain Executive Deferred Compensation payments with the issuance of 1,573,988 warrants. The fair value of the warrants totaled $251,837. The total executive Deferred Compensation that was settled with the issuance of the warrants was $167,892. The difference between the fair value of the warrants and the Executive Deferred Compensation settled of $83,945 was recorded as stock-based compensation during the year ended December 31, 2020. The total amount of equity-based compensation included in additional paid in capital was $276,641 and $225,026 for the years ended December 31, 2020 and 2019. The following is a summary of outstanding stock options issued to employees and directors as of December 31, 2020: Number of Options Exercise Average Aggregate Outstanding January 1, 2019 7,428,014 .40 - .87 5.48 Issued 1,156,343 .45 - .73 Cancelled (1,387,333 ) Outstanding December 31, 2019 7,197,024 .40 - .87 4.55 - Issued 1,069,358 .34 - .44 Cancelled/Expired (625,423 ) Outstanding December 31, 2020 7,640,959 .34 - .87 3.48 Exercisable, December 31 2020 6,667,625 .34 - .87 3.48 - As of December 31, 2020, the Company has $175,847 of total unrecognized share-based compensation expense related to unvested options, which is expected to be amortized over the remaining weighted average period of 1.51 years.

Outstanding Warrants

Outstanding Warrants	12 Months Ended
	Dec. 31, 2020
Warrants and Rights Note Disclosure [Abstract]
Outstanding Warrants	Note 11. Outstanding Warrants The following is a summary of all outstanding warrants as of December 31, 2020: Number of warrants Price per share Remaining term in years Intrinsic value at date of grant Warrants issued in connection with private placements of common stock 22,020,833 $ 0.50 - $1.00 1.34 $ - Warrants issued in connection with private placement of notes 3,465,501 $ 0.60 1.23 $ - Warrants issued in connection with settlement of deferred compensation 3,169,599 $ 0.60 3.72 $ -

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 12. Income Taxes Income tax provision (benefit) for the years ended December 31, 2020 and 2019 is summarized below: 2020 2019 Current: Federal $ - $ - State - - Total current - - Deferred: Federal (715,000 ) (937,500 ) State (235,000 ) (1,488,500 ) Total deferred (950,000 ) (2,426,000 ) Change in valuation allowance $ 950,000 $ 2,426,000 The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate before provision for income taxes. The sources and tax effect of the differences are as follows: 2020 2019 Income tax provision at the federal statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit 6.9 % 3.3 % Permanent Difference (2.5 )% (2.5 )% Effect of rate change - % - % Effect of change in valuation allowance (25.4 )% (21.8 )% - % - % Components of the net deferred income tax assets at December 31, 2020 and 2019 were as follows: 2020 2019 Net operating loss carryover $ 11,345,000 $ 10,395,000 Valuation allowance (11,345,000 ) (10,395,000 ) $ - $ - ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all of the deferred tax assets will not be recognized. After consideration of all the evidence, both positive and negative, management has determined that a $11,345,000 and $10,395,000 allowance at December 31, 2020 and 2019, respectively, is necessary to reduce the deferred tax assets to the amount that will more likely than not be realized. The increase in the valuation allowance for the current period is $950,000. As of December 31, 2020, we have a net operating loss carry forward of approximately $40,664,400. The loss will be available to offset future taxable income. If not used, this carry forward will expire as follows: 2030 $ 1,000 2031 $ 63,800 2032 $ 345,900 2033 $ 1,840,300 2034 $ 2,324,100 2035 $ 2,987,300 2036 $ 5,061,700 2037 $ 8,464,700 2038 $ 7,315,400 2039 $ 4,391,100 The 2020 and 2019 net operating loss carry forward of $3,404,600 and $4,464,500 does not expire under the Tax Cut and Job Act of 2017.

Business Segments and Customer

Business Segments and Customer Concentrations	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Business Segments and Customer Concentrations	Note 13. Business Segments and Customer Concentrations. During the years ended December 31, 2020 and 2020, we operated in one segment. The following is a breakdown of customers representing more than 10% of sales for the year ended December 31, 2020: Revenue from customer Percentage of total revenue Customer A $ 845,011 31.41 % Customer B $ 562,499 20.91 % Customer C $ 297,527 11.06 % The following is a breakdown of customers representing more than 10% of sales for the year ended December 31, 2019: Percentage Revenue from of total customer revenue Customer A $ 1,641,333 38.14 % Customer B $ 739,956 17.19 %

Liquidity

Liquidity	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity	Note 14. Liquidity We have a history of operating losses and negative cash flow from operations. These conditions raise substantial doubt over the Company’s ability to meet all of its obligations over the twelve months following the filing of this Form 10-K. Management has evaluated these conditions, and concluded that current plans will alleviate this concern. As of December 31, 2020, we had $1,959,269 of cash and restricted cash on the balance sheet. We have continued to significantly reduce core operating expenses, reducing total General and Administrative Expense in 2020 by $2,470,590 or 36%, as compared with 2019. In January 2021, the company secured $568,131 in proceeds from the second PPP loan. The Company is expecting an increase in revenue bouncing back from Covid-19 and its new Twist & Go products. The Company believes this will provide sufficient cash to cover operating expenses and $1,139,000 in debt due over the next 12 months. If there are not sufficient cash flows to cover the debt repayment the company believes that the debt could be satisfied through refinancing including conversion, raising additional proceeds through issuance of stock or new debt. With the lean initiatives implemented by the business in 2020, liquidity is expected to remain stable with very little change from 2020. Management has concluded that these actions have alleviated the substantial doubt of our ability to continue as a going concern. However, the Company cannot predict, with certainty, the outcome of its action to generate liquidity, including the availability of additional financing, or whether such actions would generate the expected liquidity as planned.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 15. Subsequent Events On January 27, 2021, the Company was granted a $568,131 loan under the PPP administered by a Small Business Administration (SBA) approved partner. The loan, which matures in five years, at an interest rate of 1%, and is uncollateralized and is fully guaranteed by the Federal government. The deferral period is 24 weeks plus 10 months from the loan note date. The Company is eligible for loan forgiveness of up to 100% of the loan, upon meeting certain requirements. The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Consolidation	Basis of Consolidation The consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.
Concentration of Credit Risk	Concentration of Credit Risk The amount of cash on deposit with financial institutions exceeds the $250,000 federally insured limit at December 31, 2020 and 2019. However, we believe that cash on deposit that exceeds $250,000 in the financial institutions is financially sound and the risk of loss is minimal.
Restricted Cash	Restricted Cash At December 31, 2020, the Company had $142,382 and $91,385, respectively, in restricted cash related to our co-packing agreement.
Fair Value Measurement	Fair Value Measurement Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 - Pricing inputs are other than quoted prices in active markets but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts or priced with models using highly observable inputs. Level 3 - Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights. Our financial instruments consist of cash, accounts receivable, accounts payable, advanced payments, derivative liabilities, convertible notes, restricted cash, and PPP loan payable. The carrying value of our financial instruments approximates their fair value, except for the derivative liability in which carrying value is fair value.
Accounts Receivable	Accounts Receivable Accounts receivable are typically unsecured. Our credit policy calls for payment generally within 30 days. The credit worthiness of a customer is evaluated prior to a sale. As of December 31, 2020, and 2019, the company’s allowance for doubtful accounts was $133,424 and $141,788 respectively. There was $133,424 of bad debt expense recorded for the year ended December 31, 2020 and $89,397 of bad debt expense for the year ended December 31, 2019. The allowance was applied to certain receivable accounts which are over 95 days.
Inventory	Inventory Inventory consists of finished goods and is carried at the lower of cost or net realizable value on a first in first out basis. The company monitors the remaining useful life of its inventory and establishes a reserve of obsolescence where appropriate. As of December 31, 2020 and 2019, the Company’s inventory reserve was $59,093 and $100,651 respectively.
Intangible Assets	Intangible Assets Intangible assets are comprised of patents, net of amortization and trademarks. The patent costs are being amortized over the life of the patent, which is twenty years from the date of filing the patent application. In accordance with ASC Topic 350 Intangibles - Goodwill and Other In accordance with ASC 350 legal costs related to trademarks have been capitalized. We have determined that trademarks have an indeterminable life and therefore are not being amortized.
Long-Lived Assets and Other Acquired Intangible Assets	Long-Lived Assets and Other Acquired Intangible Assets We evaluate the recoverability of property and equipment and finite-lived intangible assets for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If such review indicates that the carrying amount of property and equipment and intangible assets is not recoverable, the carrying amount of such assets is reduced to fair value. We have not recorded any impairment charges during the years presented.
Property, Plant, and Equipment	Property, Plant, and Equipment Property, plant, and equipment is stated at cost less accumulated depreciation and accumulated impairment loss, if any. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. Leasehold improvements are being amortized over the shorter of the useful life of the asset or the lease term that includes any expected renewal periods that are deemed to be reasonably assured. The estimated useful lives used for financial statement purposes are: Furniture and fixtures: 5 years Manufacturing equipment and customer equipment: 3 years to 7 years Vehicles: 5 years
Revenue Recognition	Revenue Recognition In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods. The Company applies the following five steps: 1) Identify the contract with a customer A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be supplemented by other agreements that formalize various terms and conditions with customers. 2) Identify the performance obligation in the contract Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company, this consists of the delivery of frozen beverages, which provide immediate benefit to the customer. 3) Determine the transaction price The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and is generally stated on the approved sales order. Variable consideration, which typically includes volume-based rebates or discounts, are estimated utilizing the most likely amount method. 4) Allocate the transaction price to performance obligations in the contract Since our contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated to that single performance obligation. 5) Recognize Revenue when or as the Company satisfies a performance obligation The Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts are treated as a reduction of sales at the time the sale is recognized. Shipping and handling costs are treated as fulfillment costs and presented in distribution, selling and administrative costs. Payments that are received before performance obligations are recorded are shown as current liabilities. The company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single product, frozen beverages.
Research and Development	Research and Development Expenditures for research activities relating to product development and improvement are charged to expense as incurred. We incurred $515,145 and $538,391, in research and development expenses for the years ended December 31, 2020 and 2019, respectively.
Shipping and Storage Costs	Shipping and Storage Costs Shipping and handling costs are included in general and administrative expenses. For the years ended December 31, 2020 and 2019, shipping and handling costs totaled $ 488,465 and $751,237, respectively.
Leases	Leases We determine if an arrangement is a lease upon inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The right to control the use of an asset includes the right to obtain substantially all of the economic benefits of the underlying asset and the right to direct how and for what purpose the asset is used. After adoption of ASU 2016-02 and related standards, operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Lease expense is recognized on a straight-line basis over the lease term. As a lessee, the Company leases office space.
Income Taxes	Income Taxes The provision for income taxes is determined in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements, uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely than not that some portion or all of the deferred tax assets will not be recognized. For the years ended December 31, 2020 and 2019 we did not have any interest and penalties or any significant unrecognized uncertain tax positions.
Derivative Liability	Derivative Liability The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging.” The result of this accounting treatment is that the fair value of any derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as gain/loss from derivative liability. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. We analyzed the derivative financial instruments in accordance with ASC 815. The objective is to provide guidance for determining whether an equity-linked financial instrument is indexed to an entity’s own stock. This determination is needed for a scope exception which would enable a derivative instrument to be accounted for under the accrual method. The classification of a non-derivative instrument that falls within the scope of ASC 815-40-05 “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” also hinges on whether the instrument is indexed to an entity’s own stock. A non-derivative instrument that is not indexed to an entity’s own stock cannot be classified as equity and must be accounted for as a liability. There is a two-step approach in determining whether an instrument or embedded feature is indexed to an entity’s own stock. First, the instrument’s contingent exercise provisions, if any, must be evaluated, followed by an evaluation of the instrument’s settlement provisions. The Company utilized the fair value standard set forth by the Financial Accounting Standards Board, defined as the amount at which the assets (or liability) could be bought (or incurred) or sold (or settled) in a current transaction between willing parties, that is, other than in a forced or liquidation sale.
Earnings Per Share	Earnings per Share We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share
Stock Based Compensation	Stock Based Compensation We calculate stock compensation in accordance with ASC Topic 718, Compensation-Stock Based Compensation
Recent Pronouncements	Recent pronouncements From time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Estimated Useful Lives of Assets	The estimated useful lives used for financial statement purposes are: Furniture and fixtures: 5 years Manufacturing equipment and customer equipment: 3 years to 7 years Vehicles: 5 years

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consists of the following at December 31: 2020 2019 Raw materials $ 130,296 $ 286,028 Finished goods 798,987 449,369 Inventory reserve (59,093 ) (100,651 ) Inventory, net $ 870,190 $ 634,746

Property Plant and Equipment (T

Property Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Schedule of Major Classes of Property and Equipment	Major classes of property and equipment at December 31, 2020 and 2019 consist of the following: 2020 2019 Furniture and fixtures $ 1,524 $ 1,524 Manufacturing Equipment and customer equipment 3,573,528 3,521,636 Leasehold Improvements 4,886 4,886 Vehicles 29,696 29,696 3,609,634 3,557,742 Less: accumulated depreciation (2,331,034 ) (1,787,967 ) 1,278,600 1,769,775 Equipment not yet placed in service 644,312 636,542 Property and equipment, net of depreciation $ 1,922,912 $ 2,406,317

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Estimated Future Amortization Expense Related to Intangible Property	Estimated future amortization expense related to patents as of December 31, 2020, is as follows: Years ending December 31, Total Amortization 2021 $ 64,422 2022 64,422 2023 64,422 2024 64,218 2025 52,821 $ 310,305

Convertible Notes (Related an_2

Convertible Notes (Related and Unrelated Party) (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Fair Value Assumptions Used	The fair value of the warrants, $0.17 per share ($220,548 in the aggregate), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 3 Volatility (based on a comparable company) 54.82 % Risk Free interest rate 2.41 % Dividend yield (on common stock) - The fair value of the warrants, $0.25 per share ($235,519 in the aggregate), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 3 Volatility (based on a comparable company) 55.49 % Risk Free interest rate 2.45 % Dividend yield (on common stock) - The fair value of the warrants, ($92,266 in the aggregate which consists of the L and P Warrants), were calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1 to 3 Volatility 76.74- 98.00 % Risk Free interest rate .15 - .41 % Dividend yield (on common stock) - The fair value of the warrants, $0.31 per share ($212,763 in the aggregate), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 3 Volatility (based on a comparable company) 59.00 % Risk Free interest rate 2.83 % Dividend yield (on common stock) - The fair value of the modified L warrants, ($4,279 prior to modification, and $6,096 post modification), was calculated using the Black-Scholes option pricing model using the following assumptions: Expected life (in years) 1.71 Volatility 88.02 % Risk Free interest rate 0.37 % Dividend yield (on common stock) -
Schedule of Convertible Notes	The convertible notes consist of the following components as of December 31, 2020 and December 31, 2019: 2020 2019 Convertible notes $ 1,181,167 $ 2,704,800 Less: Debt discount (warrant value) (92,266 ) (325,747 ) Less: Debt discount (derivative value) (Note 8) - (638,988 ) Less: Debt discount (issuance costs paid) (6,004 ) (27,000 ) Less: Note repayments/conversion (110,166 ) (803,634 ) Add: Debt discount amortization 38,173 898,940 $ 1,010,904 $ 1,808,371 The convertible notes consist of the following components as of December 31, 2020 and December 31, 2019: 2020 2019 Convertible notes $ 235,200 $ 1,363,200 Less: Debt discount (warrant value) (1,817 ) (212,763 ) Less: Debt discount (derivative value) (Note 8) (13,528 ) (697,186 ) Less: Debt discount (issuance costs paid) (6,004 ) (23,700 ) Less: Note repayments (67,200 ) - Add: Debt discount amortization 9,487 502,639 $ 156,138 $ 938,190
Schedule of Future Maturities of Convertible Notes	Future maturity of convertible notes at face value before effect of all discount, are as follow: Years Ending December 31, Total Convertible Notes 2021 $ 168,000 2022 1,071,000 $ 1,139,000

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of the Derivative Liability	The fair value of the derivative liability for CN notes that were converted and CN notes that were extended was calculated using the Black-Scholes model using the following assumptions: March 20, 2020 Expected life (in years) 0.71 Volatility 84.82 % Risk Free interest rate 0.5 % Dividend yield (on common stock) - The fair value of the derivative liability for CN2 notes that were extended was calculated using the Black-Scholes model using the following assumptions: March 20, 2020 Expected life (in years) 1.71 Volatility 88.02 % Risk Free interest rate 0.37 % Dividend yield (on common stock) - The fair value of the derivative liabilities for CN Convertible Note 2 of 2 was calculated using the Black-Scholes model using the following assumptions. December 31, 2020 December 31, 2019 Expected life 0.92 0.93 Volatility 120.38 % 104.89 % Risk Free interest rate .1 % 1.58 % Dividend yield (on common stock) - -
Schedule of Derivative Liability Measured at Fair Value on a Recurring Basis	Reconciliation of the derivative liability measured at fair value on a recurring basis with the use of significant unobservable inputs (level 3) from December 31, 2018 to December 31, 2019: December 31, 2018 $ 1,325,653 Loss from change in value (1,114,625 ) For the period ended December 31, 2019 $ 211,028 Reconciliation of the derivative liabilities measured at fair value on a recurring basis with the use of significant unobservable inputs (level 3) from December 31, 2019 to December 31, 2020: December 31, 2019 $ 211,028 Extinguishment change in derivative from conversion (23,100 ) Extinguishment change in derivative from extension (3,440 ) Initial derivative value – March 20, 2020 13,527 Net gain from change in value (156,540 ) For the period ended December 31, 2020 $ 41,475
Schedule of Fair Value Hierarchy of Assets and Liabilities	The following table presents the Company’s fair value hierarchy for applicable assets and liabilities measured at fair value as of December 31, 2019 and December 31, 2020: Level 1 Level 2 Level 3 Total Derivative Liability December 31, 2019 $ - - 211,028 $ 211,028 Level 1 Level 2 Level 3 Total Derivative Liability December 31, 2020 $ - - 41,475 $ 41,475

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Estimate Future Maturities of Lease Liabilities	The following table presents the future operating lease payment as of December 31, 2020. 2021 $ 78,021 2022 80,361 2023 20,238 Total Lease payments 178,620 Less: imputed interest (19,443 ) Total lease liability $ 159,177

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Summary of Fair Value of Options Using Black-Sholes Option Pricing Model	The fair value of the options issued ($237,850, in the aggregate) was calculated using the Black-Sholes option pricing model, based on the criteria shown below. Expected life (in years) 5.5 to 8 Volatility (based on a comparable company) 59.82% to 77.19 % Risk Free interest rate 1.79% to 2.78 % Dividend yield (on common stock) - The fair value of the options issued ($217,650, in the aggregate) was calculated using the Black-Sholes option pricing model, based on the criteria shown below. Expected life (in years) 5.5 to 8 Volatility (based on a comparable company) 73.36%-75.82 % Risk Free interest rate 0.30%-1.61 % Dividend yield (on common stock) -
Summary of Outstanding Stock Options Issued to Employees and Directors	The following is a summary of outstanding stock options issued to employees and directors as of December 31, 2020: Number of Options Exercise Average Aggregate Outstanding January 1, 2019 7,428,014 .40 - .87 5.48 Issued 1,156,343 .45 - .73 Cancelled (1,387,333 ) Outstanding December 31, 2019 7,197,024 .40 - .87 4.55 - Issued 1,069,358 .34 - .44 Cancelled/Expired (625,423 ) Outstanding December 31, 2020 7,640,959 .34 - .87 3.48 Exercisable, December 31 2020 6,667,625 .34 - .87 3.48 -

Outstanding Warrants (Tables)

Outstanding Warrants (Tables)	12 Months Ended
	Dec. 31, 2020
Warrants and Rights Note Disclosure [Abstract]
Summary of Outstanding Warrants	The following is a summary of all outstanding warrants as of December 31, 2020: Number of warrants Price per share Remaining term in years Intrinsic value at date of grant Warrants issued in connection with private placements of common stock 22,020,833 $ 0.50 - $1.00 1.34 $ - Warrants issued in connection with private placement of notes 3,465,501 $ 0.60 1.23 $ - Warrants issued in connection with settlement of deferred compensation 3,169,599 $ 0.60 3.72 $ -

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Summary of Income Tax Provision (Benefit)	Income tax provision (benefit) for the years ended December 31, 2020 and 2019 is summarized below: 2020 2019 Current: Federal $ - $ - State - - Total current - - Deferred: Federal (715,000 ) (937,500 ) State (235,000 ) (1,488,500 ) Total deferred (950,000 ) (2,426,000 ) Change in valuation allowance $ 950,000 $ 2,426,000
Summary of Statutory Federal Income Tax Rate Before Provision for Income Taxes	The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate before provision for income taxes. The sources and tax effect of the differences are as follows: 2020 2019 Income tax provision at the federal statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit 6.9 % 3.3 % Permanent Difference (2.5 )% (2.5 )% Effect of rate change - % - % Effect of change in valuation allowance (25.4 )% (21.8 )% - % - %
Schedule of Components of Net Deferred Income Tax Assets	Components of the net deferred income tax assets at December 31, 2020 and 2019 were as follows: 2020 2019 Net operating loss carryover $ 11,345,000 $ 10,395,000 Valuation allowance (11,345,000 ) (10,395,000 ) $ - $ -
Summary of Net Operating Loss Carry Forward Offset Future Taxable Income Expire	The loss will be available to offset future taxable income. If not used, this carry forward will expire as follows: 2030 $ 1,000 2031 $ 63,800 2032 $ 345,900 2033 $ 1,840,300 2034 $ 2,324,100 2035 $ 2,987,300 2036 $ 5,061,700 2037 $ 8,464,700 2038 $ 7,315,400 2039 $ 4,391,100

Business Segments and Custome_2

Business Segments and Customer Concentrations (Tables)	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments	The following is a breakdown of customers representing more than 10% of sales for the year ended December 31, 2020: Revenue from customer Percentage of total revenue Customer A $ 845,011 31.41 % Customer B $ 562,499 20.91 % Customer C $ 297,527 11.06 % The following is a breakdown of customers representing more than 10% of sales for the year ended December 31, 2019: Percentage Revenue from of total customer revenue Customer A $ 1,641,333 38.14 % Customer B $ 739,956 17.19 %

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash federally insured limit value	$ 250,000	$ 250,000
Cash on deposit exceeds	250,000
Allowance for doubtful accounts receivable	133,424	141,788
Bad debt expense	133,424	89,397
Inventory reserve	59,093	100,651
Research and development expenses	515,145	538,391
Shipping and handling costs	$ 488,465	751,237
Percentage of tax benefits likelihood being realized upon ultimate settlement	Greater than 50%
Unrecognized uncertain tax positions interest and penalties
Patents [Member]
Intangible assets useful life	20 years
Co-packing Agreement [Member]
Restricted cash	$ 142,382	$ 91,385

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Assets (Details)	12 Months Ended
	Dec. 31, 2020
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Manufacturing Equipment and Customer Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Manufacturing Equipment and Customer Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 130,296	$ 286,028
Finished goods	798,987	449,369
Inventory reserve	(59,093)	(100,651)
Inventory, net	$ 870,190	$ 634,746

Property Plant and Equipment (D

Property Plant and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 529,385	$ 586,237
Depreciation expense in Cost of Goods Sold	$ 18,938	$ 65,366

Property Plant and Equipment -

Property Plant and Equipment - Schedule of Major Classes of Property and Equipment (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,609,634	$ 3,557,742
Less: accumulated depreciation	(2,331,034)	(1,787,967)
Property and equipment	1,278,600	1,769,775
Equipment not yet placed in service	644,312	636,542
Property and equipment, net of depreciation	1,922,912	2,406,317
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,524	1,524
Manufacturing Equipment and Customer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,573,528	3,521,636
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,886	4,886
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 29,696	$ 29,696

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Patent costs	$ 768,138	$ 764,891
Trademarks costs	119,911	108,632
Accumulated amortization on patents and trademarks	$ 457,833	394,020
Expiration date of patents	Dec. 31, 2025
Amortization of intangible assets	$ 63,813	$ 63,610

Intangible Assets - Schedule of

Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Property (Details)	Dec. 31, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2021	$ 64,422
2022	64,422
2023	64,422
2024	64,218
2025	52,821
Intangible asset, net of amortization	$ 310,305

Paycheck Protection Program (_2

Paycheck Protection Program (PPP) Loan (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Proceeds from notes payable	$ 568,131
Paycheck Protection Program [Member]
Proceeds from notes payable	$ 568,131
Loan forgiven description	The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. No forgiveness income has been recorded for the year ended December 31, 2020. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven. The company has applied for and anticipates the loan to be forgiven in 2021.
Paycheck Protection Program [Member] | Maximum [Member]
Eligible loan forgiveness percentage	100.00%

Convertible Notes (Related an_3

Convertible Notes (Related and Unrelated Party) (Details Narrative)	Mar. 20, 2020USD ($)$ / sharesshares	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)$ / sharesshares	Apr. 30, 2018USD ($)Segment$ / sharesshares	Mar. 31, 2018USD ($)Segment$ / sharesshares	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Convertible notes						$ 1,167,042	$ 2,740,561
Debt conversion, description	If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the "Six Month Price") exceeds or equals $0.50 per share (the "Target Price"), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor's investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share
Fair value of warrants							307,460
Long Term Liabilities						1,139,000
Convertible note, net of discount						158,243	150,742
Convertible note related party, non-current						197,804	1,181,942
Convertible note non-current						810,995	1,407,877
Extinguishment of debt	$ 379,200					$ 379,200
Gain on extinguishment of debt	437,201
Loss on extinguishment of debt	$ 58,001
Conversion description	The gain of $437,201 related to the portion of Convertible Notes that were converted to common stock on March 20, 2020. The loss on extinguishment of debt of $58,001 related to the portion of Convertible Notes that were extended by either 24 months for CN I, or 12 months for CN2.
Private Placement Offering [Member]
Debt conversion, description						If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the "Six Month Price") exceeds or equals $0.50 per share (the "Target Price"), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor's investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share
Proceeds from private placement	$ 3,825,000					$ 3,825,000
Investors [Member]
Principal balance converted into common stock		$ 350,634
Accrued interest		$ 33,929
March 2018 Convertible Note [Member]
Convertible notes				$ 177,300
Notes purchased by significant shareholder				$ 30,000
Debt interest rate				10.00%
Debt maturity date				Mar. 14, 2020
Debt conversion price | $ / shares				$ 0.88
Closing price of the common stock, percentage				85.00%
Consecutive trading days | Segment				20
Debt conversion, description				The notes are convertible at any time prior to the due date into our common stock at conversion price of $0.88 per share or 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders' election; but in no event lower than $0.60 per share.
March 2018 Convertible Note One [Member]
Closing price of the common stock, percentage				85.00%
Debt conversion, description				In addition, the interest is convertible at any time prior to the due dates into our common stock at conversion price of 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders' election; but in no event lower than $0.60 per share. There were 937,373 warrants issued in conjunction with the Series CN Note acceleration offer convertible note offering.
Warrant [Member]
Warrant issued | shares			678,864	937,373	1,331,583
Fair value of warrant per share | $ / shares			$ 0.31	$ 0.25	$ 0.17
Fair value of warrants			$ 212,763	$ 235,519	$ 220,548
Debt discount			212,763	$ 105,199	220,548
Series CN Note 1 of 2 [Member]
Convertible notes					2,527,500
Notes purchased by significant shareholder					$ 840,000
Debt interest rate					10.00%
Debt maturity date					Mar. 14, 2020
Debt conversion price | $ / shares					$ 0.88
Closing price of the common stock, percentage					85.00%
Consecutive trading days | Segment					20
Debt conversion, description					The notes are convertible at any time prior to the due date into our common stock at conversion price of $0.88 per share or 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders' election; but in no event lower than $0.60 per share.
Series CN Notes investors [Member] | Minimum [Member]
Debt instrument effective rate				10.00%
Series CN Notes investors [Member] | Maximum [Member]
Debt instrument effective rate				20.00%
Series CN Notes investors [Member] | Warrants [Member]
Debt instrument effective rate				25.00%
Series CN Convertible Notes 1 [Member]
Convertible notes	$ 1,071,000
Debt interest rate	15.00%
Debt maturity date	Mar. 20, 2022
Debt conversion price | $ / shares	$ 0.50
Closing price of the common stock, percentage	50.00%
Debt conversion, description	The notes are convertible at any time prior to the maturity into our common stock at a conversion price of $0.50 per share. If the six month price is less than the $0.50 per share, the principal conversion price will be automatically reduced to the $0.50 per share, but in no event less than $0.35 per Share, in which case the Company shall issue to each purchaser, based on such purchaser's investment, (a) shares in a quantity that equals the difference between the number of Shares issued to such purchaser at closing and the number of Shares that would have been issued to such purchaser at closing at the $0.50 per share and (b) warrants in a quantity that equals fifty percent (50%) of the difference between the number of shares issued to such Purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the $0.50 per share, with an exercise price that equals the sum of $0.10 per share and the $0.50 per share, but in no event less than $0.45 per share.
Principal balance converted into common stock	$ 720,000
Due from related parties	$ 630,000
Debt instrument conversion of common stock percentage	20.00%
Remaining convertible notes	$ 1,186,167
Series CN Convertible Notes 1 [Member] | O Warrants [Member]
Warrant issued | shares	864,000
Series CN Convertible Notes 1 [Member] | L Warrants [Member]
Warrant issued | shares	1,082,727
Series CN Convertible Notes 1 [Member] | L Warrants [Member] | Minimum [Member]
Warrant exercise price | $ / shares	$ 0.50
Series CN Convertible Notes 1 [Member] | L Warrants [Member] | Maximum [Member]
Warrant exercise price | $ / shares	$ 0.70
Series CN Convertible Notes 1 [Member] | P Warrants [Member]
Warrant granted | shares	1,071,000
Series CN Convertible Notes 1 [Member] | L and P Warrants [Member]
Fair value of warrants	$ 92,266
Series CN Note 1 and 2 [Member] | P Warrants [Member]
Fair value of warrants	17,082
Debt discount	75,184
Series CN Note 2 of 2 [Member]
Convertible notes			1,363,200
Notes purchased by significant shareholder			$ 560,000
Debt interest rate			10.00%
Debt maturity date			Nov. 30, 2020
Debt conversion price | $ / shares			$ 0.88
Closing price of the common stock, percentage			85.00%
Debt conversion, description			The notes are convertible at any time prior to the due date into our common stock at conversion price of $0.88 per share or 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders' election; but in no event lower than $0.60 per share.
Convertible Notes [Member]
Closing price of the common stock, percentage			85.00%
Debt conversion, description			In addition, the interest is convertible at any time prior to the due dates into our common stock at conversion price of 85% of the average closing price of the common stock over the twenty consecutive trading days immediately preceding the date of note holders' election; but in no event lower than $0.60 per share. There were 678,864 warrants issued, in conjunction with the convertible note offering.
Series CN Convertible Notes 2 [Member]
Convertible notes	$ 168,000
Debt interest rate	60.00%
Debt maturity date	Nov. 30, 2021
Principal balance converted into common stock	$ 1,128,000
Due from related parties	$ 560,000
Debt instrument conversion of common stock percentage	20.00%
Remaining convertible notes	$ 235,200
Series CN Convertible Notes 2 [Member] | O Warrants [Member]
Warrant issued | shares	1,501,012
Series CN Convertible Notes 2 [Member] | L Warrants [Member]
Debt discount	$ 1,817
Series CN Convertible Notes 2 [Member] | L Warrants [Member] | Pre Modification [Member]
Fair value of warrants	4,279
Series CN Convertible Notes 2 [Member] | L Warrants [Member] | Post Modification [Member]
Fair value of warrants	$ 6,096

Convertible Notes (Related an_4

Convertible Notes (Related and Unrelated Party) - Schedule of Fair Value Assumptions Used (Details)	Mar. 20, 2020	Dec. 31, 2018	Apr. 30, 2018	Mar. 31, 2018
Expected Life [Member]
Fair value assumptions, measurement input, term		3 years	3 years	3 years
Expected Life [Member] | L and P Warrants [Member] | Minimum [Member]
Fair value assumptions, measurement input, term	1 year
Expected Life [Member] | L and P Warrants [Member] | Maximum [Member]
Fair value assumptions, measurement input, term	3 years
Expected Life [Member] | L Warrants [Member]
Fair value assumptions, measurement input, term	1 year 8 months 16 days
Volatility [Member]
Fair value assumptions, measurement input, percentage		59.00%	55.49%	54.82%
Volatility [Member] | L and P Warrants [Member] | Minimum [Member]
Fair value assumptions, measurement input, percentage	76.74%
Volatility [Member] | L and P Warrants [Member] | Maximum [Member]
Fair value assumptions, measurement input, percentage	98.00%
Volatility [Member] | L Warrants [Member]
Fair value assumptions, measurement input, percentage	88.02%
Risk Free Interest Rate [Member]
Fair value assumptions, measurement input, percentage		2.83%	2.45%	2.41%
Risk Free Interest Rate [Member] | L and P Warrants [Member] | Minimum [Member]
Fair value assumptions, measurement input, percentage	0.15%
Risk Free Interest Rate [Member] | L and P Warrants [Member] | Maximum [Member]
Fair value assumptions, measurement input, percentage	0.41%
Risk Free Interest Rate [Member] | L Warrants [Member]
Fair value assumptions, measurement input, percentage	0.37%
Dividend Yield [Member]
Fair value assumptions, measurement input, percentage		0.00%	0.00%	0.00%
Dividend Yield [Member] | L and P Warrants [Member]
Fair value assumptions, measurement input, percentage	0.00%
Dividend Yield [Member] | L Warrants [Member]
Fair value assumptions, measurement input, percentage	0.00%

Convertible Notes (Related an_5

Convertible Notes (Related and Unrelated Party) - Schedule of Convertible Notes (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Total convertible notes	$ 1,167,042	$ 2,740,561
Convertible Note One[Member]
Convertible notes	1,181,167	2,704,800
Less: Debt discount (warrant value)	(92,266)	(325,747)
Less: Debt discount (derivative value)		(638,988)
Less: Debt discount (issuance costs paid)	(6,004)	(27,000)
Less: Note repayments/conversion	(110,166)	(803,634)
Add: Debt discount amortization	38,173	898,940
Total convertible notes	1,010,904	1,808,371
Convertible Note Two [Member]
Convertible notes	235,200	1,363,200
Less: Debt discount (warrant value)	(1,817)	(212,763)
Less: Debt discount (derivative value)	(13,528)	(697,186)
Less: Debt discount (issuance costs paid)	(6,004)	(23,700)
Less: Note repayments/conversion	(67,200)
Add: Debt discount amortization	9,487	502,639
Total convertible notes	$ 156,138	$ 932,190

Convertible Notes (Related an_6

Convertible Notes (Related and Unrelated Party) - Schedule of Future Maturities of Convertible Notes (Details)	Dec. 31, 2020USD ($)
Debt Disclosure [Abstract]
Years ending December 31, 2021	$ 168,000
Years ending December 31, 2022	1,071,000
Future maturity of convertible notes, total	$ 1,139,000

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Mar. 20, 2020
Revalued derivative liability		$ 211,028
Gain on derivative liabilities	$ 156,540	$ 1,114,625
Fair value of derivative liability			$ 13,527
CN1 and CN2 [Member]
Fair value of derivative liability			23,100
Convertable Notes Extended [Member]
Fair value of derivative liability			3,440
Convertable Note Two Extended [Member]
Fair value of derivative liability			$ 168,000

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Fair Value of the Derivative Liability (Details)	Mar. 20, 2020	Dec. 31, 2018	Apr. 30, 2018	Mar. 31, 2018	Dec. 31, 2020	Dec. 31, 2019
Expected Life [Member]
Fair value assumptions, measurement input, term		3 years	3 years	3 years
Derivative Liabilities [Member] | CN Notes Converted and Extended [Member] | Expected Life [Member]
Fair value assumptions, measurement input, term	8 months 16 days
Derivative Liabilities [Member] | CN Notes Converted and Extended [Member] | Volatility [Member]
Fair value assumptions, measurement input, percentage	84.82
Derivative Liabilities [Member] | CN Notes Converted and Extended [Member] | Risk Free Interest Rate [Member]
Fair value assumptions, measurement input, percentage	0.5
Derivative Liabilities [Member] | CN Notes Converted and Extended [Member] | Dividend Yield [Member]
Fair value assumptions, measurement input, percentage	0
Derivative Liabilities [Member] | Convertable Note Two [Member] | Expected Life [Member]
Fair value assumptions, measurement input, term	1 year 8 months 16 days
Derivative Liabilities [Member] | Convertable Note Two [Member] | Volatility [Member]
Fair value assumptions, measurement input, percentage	88.02
Derivative Liabilities [Member] | Convertable Note Two [Member] | Risk Free Interest Rate [Member]
Fair value assumptions, measurement input, percentage	0.37
Derivative Liabilities [Member] | Convertable Note Two [Member] | Dividend Yield [Member]
Fair value assumptions, measurement input, percentage	0
Derivative Liabilities [Member] | Series CN Convertible Note 2 of 2 [Member] | Expected Life [Member]
Fair value assumptions, measurement input, term					11 months 1 day	11 months 4 days
Derivative Liabilities [Member] | Series CN Convertible Note 2 of 2 [Member] | Volatility [Member]
Fair value assumptions, measurement input, percentage					120.38	104.89
Derivative Liabilities [Member] | Series CN Convertible Note 2 of 2 [Member] | Risk Free Interest Rate [Member]
Fair value assumptions, measurement input, percentage					0.1	1.58
Derivative Liabilities [Member] | Series CN Convertible Note 2 of 2 [Member] | Dividend Yield [Member]
Fair value assumptions, measurement input, percentage					0	0

Derivative Liabilities - Sche_2

Derivative Liabilities - Schedule of Derivative Liability Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Derivative liabilities, beginning balance	$ 211,028	$ 1,325,653
Extinguishment change in derivative from conversion	(23,100)
Extinguishment change in derivative from extension	(3,440)
Initial derivative value - March 20, 2020	13,527
Net gain (loss) from change in value	(156,540)	(1,114,625)
Derivative liabilities, ending balance	$ 41,475	$ 211,028

Derivative Liabilities - Sche_3

Derivative Liabilities - Schedule of Fair Value Hierarchy of Assets and Liabilities (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Derivative Liability	$ 41,475	$ 211,028
Fair Value, Inputs, Level 1 [Member]
Derivative Liability
Fair Value, Inputs, Level 2 [Member]
Derivative Liability
Fair Value, Inputs, Level 3 [Member]
Derivative Liability	$ 41,475	$ 211,028

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Operating lease expire date	Mar. 31, 2023
Lease expense	$ 82,194	$ 92,608
Right use of asset	147,947	$ 203,287
Lease liability	$ 159,177
Lease discount rate	10.00%
Remaining lease term	2 years 2 months 30 days
Legal proceeding amount	$ 100,000

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Estimate Future Maturities of Lease Liabilities (Details)	Dec. 31, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
2021	$ 78,021
2022	80,361
2023	20,238
Total Lease payments	178,620
Less: imputed interest	(19,443)
Total lease liability	$ 159,177

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Sep. 28, 2020	Mar. 20, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Number of common stock issued for services, value			$ 130,000
Common stock shares issued, value			$ 3,797,800	$ 2,400,000
Stock option exercisable term			8 years
Stock option vesting period			3 years
Fair value of stock options issued				$ 237,850
Cancellation of options			625,423	1,387,333
Number of options to purchase common stock			1,069,358	1,156,343
Convertible debt			$ 1,167,042	$ 2,740,561
Equity-based compensation included additional paid in capital			276,641	225,026
Debt conversion, description		If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the "Six Month Price") exceeds or equals $0.50 per share (the "Target Price"), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor's investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share
Fair value of warrants				$ 307,460
Unrecognized share-based compensation expense			$ 175,847
Unrecognized share-based compensation weighted average period			1 year 6 months 3 days
O Warrants [Member]
Class of Stock [Line Items]
Stock option exercisable term			3 years
Common stock trading price per share			$ 0.50
Private Placement Offering [Member]
Class of Stock [Line Items]
Common stock shares issued, shares	5,322,868			4,000,000
Common stock shares issued, value				$ 2,400,000
Common stock trading price per share				$ 0.60
Number of options to purchase common stock			7,650,000
Stock issued price per shares			$ 0.50
Proceeds from private placement		$ 3,825,000	$ 3,825,000
Debt conversion, description			If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the "Six Month Price") exceeds or equals $0.50 per share (the "Target Price"), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $0.35 per share, in which case the Company shall issue to each investor, pro-rata based on such investor's investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for a number of shares of common stock equal to 50% of the difference between the number of shares issued to such investor at closing and the number of shares that would have been issued to such investor at closing at the Six Month Price, with an exercise price equal to the sum of $0.10 per share and the Six Month Price, but in no eventless than $0.45 per share. The exercise price per share for each warrant will automatically adjust to the sum of $0.10 per share and the Six-Month Price, but in no event less than $0.45 per share
Weighted average price per share	$ 0.35
Private Placement Offering [Member]
Class of Stock [Line Items]
Number of warrants issued to investors	2,652,868
Number of warrants issued on debt conversion	459,000
Warrants [Member]
Class of Stock [Line Items]
Number of warrants exercised				2,841,454
Proceeds from issuance of warrants				$ 1,320,313
Convertible debt				$ 384,563
Common stock received during period				2,841,454
Warrants [Member]
Class of Stock [Line Items]
Number of warrants exercised				300,000
Proceeds from issuance of warrants				$ 180,000
Common stock received during period				300,000
Minimum [Member]
Class of Stock [Line Items]
Exercise price of options ranged			$ 0.34	$ 0.40	$ 0.40
Stock issued price per shares			0.25
Minimum [Member] | O Warrants [Member]
Class of Stock [Line Items]
Warrant exercise price			0.60
Maximum [Member]
Class of Stock [Line Items]
Exercise price of options ranged			0.87	0.87	$ 0.87
Stock issued price per shares			$ 0.50
Date of Grant [Member]
Class of Stock [Line Items]
Common stock trading price per share				0.45
Date of Grant One [Member]
Class of Stock [Line Items]
Common stock trading price per share				$ 0.73
Executive Deferred Compensation [Member]
Class of Stock [Line Items]
Common stock shares issued, value				$ 771,113
Exercise price of options ranged				$ 0.70
Stock option exercisable term				5 years
Number of warrants exercised				487,246
Executive deferred compensation payments with the issuance of warrants			1,573,988
Fair value of warrants			$ 251,837
Issuance of warrants			167,892
Stock based compensation			$ 83,945
Executive Deferred Compensation [Member] | Paid in Cash [Member]
Class of Stock [Line Items]
Common stock shares issued, value				$ 243,623
Option [Member]
Class of Stock [Line Items]
Number of common stock issued for services			272,559
Common stock shares issued, shares			654,651
Common stock shares issued, value			$ 392,789
Stock option exercisable term			8 years
Stock option vesting period			3 years
Fair value of stock options issued			$ 217,650
Cancellation of options			625,423
Options expired			625,423
Board of Directors [Member]
Class of Stock [Line Items]
Number of common stock issued for services				282,944
Number of common stock issued for services, value				$ 169,040
Common stock shares issued, shares				91,653
Common stock shares issued, value				$ 50,000
Stock option exercisable term				8 years
Board of Directors [Member] | Minimum [Member]
Class of Stock [Line Items]
Exercise price of options ranged				$ 0.47
Board of Directors [Member] | Maximum [Member]
Class of Stock [Line Items]
Exercise price of options ranged				$ 0.65
Board of Directors [Member] | Stock Option [Member]
Class of Stock [Line Items]
Common stock shares issued, shares				281,343
Common stock shares issued, value				$ 116,874
Employees and Executives [Member]
Class of Stock [Line Items]
Stock option exercisable term				8 years
Stock option vesting period				3 years
Option issued to purchase common stock				875,000
Executives [Member]
Class of Stock [Line Items]
Cancellation of options			1,387,333
Employees [Member]
Class of Stock [Line Items]
Exercise price of options ranged			$ 0.34
Number of options to purchase common stock			870,000
Board Members [Member]
Class of Stock [Line Items]
Exercise price of options ranged			$ 0.44
Number of options to purchase common stock			199,358

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Fair Value of Options Using Black-Sholes Option Pricing Model (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Volatility (based on a comparable company), minimum	73.36%	59.82%
Volatility (based on a comparable company), maximum	75.82%	77.19%
Risk Free interest rate. minimum	0.30%	1.79%
Risk Free interest rate, maximum	1.61%	2.78%
Dividend yield (on common stock)	0.00%	0.00%
Minimum [Member]
Expected life (in years)	5 years 6 months	5 years 6 months
Maximum [Member]
Expected life (in years)	8 years	8 years

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Outstanding Stock Options Issued to Employees and Directors (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Number of Options, Outstanding, Beginning	7,197,024	7,428,014
Number of Options, Issued	1,069,358	1,156,343
Number of Options, Cancelled/Expired	(625,423)	(1,387,333)
Number of Options, Outstanding, Ending	7,640,959	7,197,024
Number of Options, Exercisable	6,667,625
Average remaining term in years, Outstanding, Beginning	4 years 6 months 18 days	5 years 5 months 23 days
Average remaining term in years, Outstanding, Ending	3 years 5 months 23 days	4 years 6 months 18 days
Average remaining term in years, Exercisable	3 years 5 months 23 days
Aggregate intrinsic value at date of grant, Outstanding, Beginning
Aggregate intrinsic value at date of grant, Outstanding, Ending
Aggregate intrinsic value at date of grant, Exercisable
Minimum [Member]
Exercise price per share, Outstanding, Beginning	$ 0.40	$ 0.40
Exercise price per share, Issued	0.34	0.45
Exercise price per share, Outstanding, Ending	0.34	0.40
Exercise price per share, Exercisable	0.34
Maximum [Member]
Exercise price per share, Outstanding, Beginning	0.87	0.87
Exercise price per share, Issued	0.44	0.73
Exercise price per share, Outstanding, Ending	0.87	$ 0.87
Exercise price per share, Exercisable	$ 0.87

Outstanding Warrants - Summary

Outstanding Warrants - Summary of Outstanding Warrants (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Settlement of Deferred Compensation [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants | shares	3,169,599
Price per share	$ 0.60
Remaining term in years	3 years 8 months 19 days
Intrinsic value at date of grant | $
Private Placements of Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants | shares	22,020,833
Remaining term in years	1 year 4 months 2 days
Intrinsic value at date of grant | $
Private Placements of Common Stock [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Price per share	$ 0.50
Private Placements of Common Stock [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Price per share	$ 1
Private Placement of Notes [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants | shares	3,465,501
Price per share	$ 0.60
Remaining term in years	1 year 2 months 23 days
Intrinsic value at date of grant | $

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Deferred tax net operating loss carryover	$ 11,345,000	$ 10,395,000
Change in valuation allowance	950,000	2,426,000
Net operating loss carry forward	40,664,400
Net operating loss carry forward amount does not expire under the Tax Cut and Job Act of 2017	$ 3,404,600	$ 4,464,500

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Provision (Benefit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Current: Federal
Current: State
Total current
Deferred: Federal	(715,000)	(937,500)
Deferred: State	(235,000)	(1,488,500)
Total deferred	(950,000)	(2,426,000)
Change in valuation allowance	$ 950,000	$ 2,426,000

Income Taxes - Summary of Statu

Income Taxes - Summary of Statutory Federal Income Tax Rate Before Provision for Income Taxes (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income tax provision at the federal statutory rate	21.00%	21.00%
State income taxes, net of federal benefit	6.90%	3.30%
Permanent Difference	(2.50%)	(2.50%)
Effect of rate change	0.00%	0.00%
Effect of change in valuation allowance	(25.40%)	(21.80%)
Effective income tax rate, Total	0.00%	0.00%

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Net Deferred Income Tax Assets (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Net operating loss carryover	$ 11,345,000	$ 10,395,000
Valuation allowance	(11,345,000)	(10,395,000)
Deferred income tax assets, net

Income Taxes - Summary of Net O

Income Taxes - Summary of Net Operating Loss Carry Forward Offset Future Taxable Income Expire (Details)	12 Months Ended
	Dec. 31, 2020USD ($)
2030 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	$ 1,000
2031 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	63,800
2032 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	345,900
2033 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	1,840,300
2034 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	2,324,100
2035 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	2,987,300
2036 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	5,061,700
2037 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	8,464,700
2038 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	7,315,400
2039 [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carry forward future expiration amount	$ 4,391,100

Business Segments and Custome_3

Business Segments and Customer Concentrations (Details Narrative) - Segment	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting [Abstract]
Number of business segment	1	1

Business Segments and Custome_4

Business Segments and Customer Concentrations - Schedule of Revenue by Major Customers by Reporting Segments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue from customer	$ 2,567,547	$ 4,306,785
Customer A [Member]
Revenue from customer	$ 845,011	$ 1,641,333
Percentage of total revenue	31.41%	38.14%
Customer B [Member]
Revenue from customer	$ 562,499	$ 739,956
Percentage of total revenue	20.91%	17.19%
Customer C [Member]
Revenue from customer	$ 297,527
Percentage of total revenue	11.06%

Liquidity (Details Narrative)

Liquidity (Details Narrative) - USD ($)	Jan. 27, 2021	Jan. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash and restricted cash			$ 1,959,269	$ 1,091,374	$ 1,041,569
Reducing general and administrative expenses, description			We have continued to significantly reduce core operating expenses, reducing total General and Administrative Expense in 2020 by $2,470,590 or 36%, as compared with 2019. In January 2021, the company secured $568,131 in proceeds from the second PPP loan.
Reducing general and administrative expenses			$ 2,470,590
Proceeds from notes payable			568,131
Long term debt			1,139,000
Paycheck Protection Program [Member]
Proceeds from notes payable			$ 568,131
Subsequent Event [Member] | Paycheck Protection Program [Member]
Proceeds from notes payable	$ 568,131	$ 568,131

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Jan. 27, 2021	Jan. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Proceeds from notes payable			$ 568,131
Paycheck Protection Program [Member]
Proceeds from notes payable			$ 568,131
Loan forgiven Description			The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. No forgiveness income has been recorded for the year ended December 31, 2020. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven. The company has applied for and anticipates the loan to be forgiven in 2021.
Subsequent Event [Member] | Paycheck Protection Program [Member]
Proceeds from notes payable	$ 568,131	$ 568,131
Eligible loan forgiveness percentage	100.00%
Loan forgiven Description	The loan, which matures in five years, at an interest rate of 1%, and is uncollateralized and is fully guaranteed by the Federal government. The deferral period is 24 weeks plus 10 months from the loan note date. The Company is eligible for loan forgiveness of up to 100% of the loan, upon meeting certain requirements. The Company has recorded a note payable and will record the forgiveness upon being legally released from the loan obligation by the SBA. The Company will be required to repay any remaining balance, plus interest accrued at 1 percent, in monthly payments commencing upon notification that the loan will not be forgiven or only partially forgiven